Merck's Gardasil approved for anal cancer in US
This article was originally published in Scrip
Executive Summary
Merck’s vaccine Gardasil won approval Wednesday from the US FDA to prevent anal cancer and associated precancerous lesions associated with the human papillomavirus (HPV) types 6, 11, 16, and 18 in people 9 to 26 years.